Januvia Lawyer Interviews
June 24, 2017. By Brenda Craig.
Philadelphia, PA Final results from two independent clinical trials indicate the amputation risk for users of the Type 2 Diabetes drug Canagliflozin, marketed as Invokana, Invokamet, Invokamet XR, are much greater than previously understood.Read [ FDA Black Box Warning Adds Fuel to Invokana Lawsuits ]
August 23, 2013. By Brenda Craig.
Read [ Proving the Case - Pancreatic Cancer Patients Point Finger at Diabetes Drugs ]
April 20, 2013. By Heidi Turner.
Read [ Januvia Attorney: Januvia Lawsuits Moving Ahead ]
March 8, 2013. By Heidi Turner.
Read [ Januvia Studies Link Medication to Serious Side Effects ]